Bionano Genomics, Inc. financial data

Symbol
BNGO on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 159% % 8.8%
Quick Ratio 39% % -1.4%
Debt-to-equity 74% % -19%
Return On Equity -86% % 51%
Return On Assets -50% % 46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10,176,000 shares -90%
Common Stock, Shares, Outstanding 9,730,400 shares -89%
Entity Public Float $41,594,000 USD -79%
Common Stock, Value, Issued $1,000 USD -89%
Weighted Average Number of Shares Outstanding, Basic 5,338,000 shares 273%
Weighted Average Number of Shares Outstanding, Diluted 5,338,000 shares 273%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $28,720,000 USD -14%
Research and Development Expense $11,621,000 USD -65%
Costs and Expenses $49,946,000 USD -57%
Operating Income (Loss) $36,744,000 USD 69%
Nonoperating Income (Expense) $1,811,000 USD 90%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $38,555,000 USD 72%
Income Tax Expense (Benefit) $32,000 USD -42%
Net Income (Loss) Attributable to Parent $38,587,000 USD 72%
Earnings Per Share, Basic -11 USD/shares 98%
Earnings Per Share, Diluted -11 USD/shares 98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,065,000 USD -65%
Accounts Receivable, after Allowance for Credit Loss, Current $4,526,000 USD -15%
Inventory, Net $8,424,000 USD -48%
Other Assets, Current $1,318,000 USD 35%
Assets, Current $48,800,000 USD 3.9%
Property, Plant and Equipment, Net $16,172,000 USD -19%
Operating Lease, Right-of-Use Asset $3,497,000 USD 23%
Intangible Assets, Net (Excluding Goodwill) $5,685,000 USD -49%
Other Assets, Noncurrent $1,762,000 USD -36%
Assets $79,062,000 USD -9.5%
Accounts Payable, Current $5,990,000 USD -31%
Employee-related Liabilities, Current $2,634,000 USD -34%
Accrued Liabilities, Current $4,706,000 USD -20%
Contract with Customer, Liability, Current $1,180,000 USD -1.3%
Liabilities, Current $22,977,000 USD -30%
Contract with Customer, Liability, Noncurrent $192,000 USD -27%
Operating Lease, Liability, Noncurrent $2,599,000 USD 50%
Liabilities $29,263,000 USD -24%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,000 USD -100%
Retained Earnings (Accumulated Deficit) $711,687,000 USD -5.7%
Stockholders' Equity Attributable to Parent $49,799,000 USD 1.9%
Liabilities and Equity $79,062,000 USD -9.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,764,000 USD 90%
Net Cash Provided by (Used in) Financing Activities $10,891,000 USD
Net Cash Provided by (Used in) Investing Activities $14,066,000 USD -130%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 9,730,400 shares -89%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,948,000 USD -172%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,065,000 USD -67%
Interest Paid, Excluding Capitalized Interest, Operating Activities $479,000 USD -91%
Deferred Tax Assets, Valuation Allowance $140,472,000 USD 27%
Deferred Tax Assets, Gross $143,696,000 USD 20%
Operating Lease, Liability $3,624,000 USD -1.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $40,115,000 USD 70%
Lessee, Operating Lease, Liability, to be Paid $4,778,000 USD 18%
Property, Plant and Equipment, Gross $46,081,000 USD 8.6%
Operating Lease, Liability, Current $1,025,000 USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year Two $769,000 USD 41%
Lessee, Operating Lease, Liability, to be Paid, Year One $782,000 USD -70%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,154,000 USD 231%
Lessee, Operating Lease, Liability, to be Paid, Year Three $804,000 USD 217%
Deferred Tax Assets, Operating Loss Carryforwards $113,907,000 USD 24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $6,943,000 USD 39%
Lessee, Operating Lease, Liability, to be Paid, Year Four $840,000 USD
Operating Lease, Payments $816,000 USD 22%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,434,000 USD -19%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $5,544,000 USD -50%
Interest Expense $5,165,000 USD 1639%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%